日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Autoencoders decode polyunsaturated fatty acid metabolism with strong genetic architecture in cancer risk

自编码器解码多不饱和脂肪酸代谢,其在癌症风险中具有强大的遗传结构。

Liu, Wanshan; Gao, Hengjun; Qian, Kun

Technical Specification for Hemocompatibility Assessment of Human Mesenchymal Stem Cells

人类间充质干细胞血液相容性评估技术规范

Liu, Jialing; Liang, Weiyang; Xia, Wenjie; Wang, Ping; Hao, Jie; Na, Tao; Yan, Sunxing; Zhang, Yu; Li, Ka; Li, Qiyuan; Pan, Guangjin; Wei, Jun; Chen, Qubo; Cao, Jiani; Zhai, Peijun; Fu, Boqiang; Gao, Hengjun; Zhang, Yong; Wang, Lei; Guo, Meimei; Hu, Shijun; Zhu, Lijun; Zhao, Yang; Zhang, Weiqi; Wu, Zhihong; Ping, Yifang; Zhao, Hongling; Niu, Shuaishuai; Zhao, Tongbiao; Ma, Aijin; Xiang, Andy Peng; Chen, Xiaoyong

Remimazolam and Postoperative Delirium in Patients with Hyperlipidemia: A Retrospective Cohort Study with Target Trial Emulation Analysis

瑞米唑仑与高脂血症患者术后谵妄:一项回顾性队列研究及目标试验模拟分析

Tang, Yuling; Long, Menghong; Gao, Yuhang; Kowark, Ana; Coburn, Mark; Wan, Hengjun; Li, Yiyun; Duan, Xiaoxia

Flexible and Tunable Piezoresistive Sensors Based on Graphite-Loaded CTBN-Toughened Epoxy Composites

基于石墨掺杂CTBN增韧环氧树脂复合材料的柔性可调压阻传感器

Chen, Hengjun; Wen, Xudong; Cao, Ke; Chen, PingAn; Chen, Zenghui; Li, Xiaojun

Clinicopathological characteristics and treatment outcomes of biliary neuroendocrine carcinoma: a single-center case series and literature review

胆道神经内分泌癌的临床病理特征及治疗结果:单中心病例系列及文献综述

Liu, Zhipeng; Yang, Faji; Hao, Yijie; Zhao, Yuan; Zhang, Shizhe; Niu, Zheyu; Wang, Xin; Sun, Liyang; Zhu, Huaqiang; Cui, Fengyun; Lu, Jun; Gao, Hengjun; Zhou, Xu

Comparative outcomes of hepaticojejunostomy versus ERCP-Guided metal stenting for malignant distal biliary obstruction: a single-center retrospective study

肝空肠吻合术与ERCP引导下金属支架置入术治疗恶性远端胆道梗阻的疗效比较:一项单中心回顾性研究

Zhipeng, Liu; Ziqiang, Han; Shizhe, Zhang; Ruilan, Yu; Yupeng, Jiang; Yijie, Hao; Zheyu, Niu; Xin, Wang; Jun, Lu; Hengjun, Gao; Faji, Yang

Efficacy, safety and exploratory analysis of neoadjuvant tislelizumab (a PD-1 inhibitor) plus nab-paclitaxel followed by epirubicin/cyclophosphamide for triple-negative breast cancer: a phase 2 TREND trial

新辅助替雷利珠单抗(一种PD-1抑制剂)联合白蛋白紫杉醇序贯表柔比星/环磷酰胺治疗三阴性乳腺癌的疗效、安全性及探索性分析:一项II期TREND试验

Qiang Zhang # ,Mozhi Wang # ,Yumeng Li ,Hengjun Zhang ,Yusong Wang ,Xiuyun Chen ,Litong Yao ,Mingke Cui ,Haoran Dong ,Xiang Li ,Jian Liu ,Bo Zhu ,Yingying Xu

Structural basis for DNA break sensing by human MRE11-RAD50-NBS1 and its regulation by telomeric factor TRF2

人类MRE11-RAD50-NBS1感知DNA断裂的结构基础及其受端粒因子TRF2调控

Fan, Yilan; Kuybu, Filiz; Cui, Hengjun; Lammens, Katja; Chen, Jia-Xuan; Kugler, Michael; Jung, Christophe; Hopfner, Karl-Peter

Agricultural greenhouses datasets of 2010, 2016, and 2022 in China

中国2010年、2016年和2022年农业温室数据集

Sun, Yan; Zhang, Yuyun; Hao, Jian; Li, Jiang; Ge, Hengjun; Jiang, Feifei; Liu, Junna; Dong, Xueqing; Guo, Jiayuan; Luo, Zhanbin; Chen, Fu

Shengxian decoction alleviates cyclophosphamide-induced immunosuppression via improving B cell-mediated immune responses.

生仙汤通过改善 B 细胞介导的免疫反应来缓解环磷酰胺引起的免疫抑制

Yang Chengyu, Xu Ya, Gong Fenfang, Li Silu, Zhan Huang, Huang Zhixuan, Wang Maolin, Li Hui, Huang Hengjun